The European Medicines Agency (EMA) is a regulatory body responsible for the evaluation and supervision of medicinal products in the European Union (EU). Established in 1995, its main goal is to ensure that medicines are safe, effective, and of high quality for patients across Europe. The EMA plays a crucial role in the approval process for new drugs and monitors their safety after they are on the market. The agency works closely with national regulatory authorities in EU member states and provides scientific advice to pharmaceutical companies during the development of new medicines. By fostering collaboration and sharing information, the EMA helps to streamline the approval process and enhance public health across Europe.